BioWorld MedTech

May 19, 2011

New generation stents just what the doctor ordered

PARIS – "In 10 years we will look back and laugh at the time we left pieces of metal in people's arteries!" said John Ormiston, MD, from Auckland City Hospital (Auckland, New Zealand). (Medical Device Daily) Read More

BSX receives favorable results in Watchman study

Medtronic launches new Kyphon Xpede Bone Cement

Washington roundup: FDA, Lifecell parrying over IDE requirement for Strattice

Deals roundup: Shire Pharma set to acquire ABH for $750 million in cash

International report: Cynosure reports receipt of two new clearances

Med-Tech Notes

Product Briefs

Agreements/contracts: Labsco to distribute Cepheid's GeneXpert

Financings roundup: Cameron Health completes new $107M funding round

People in the News

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...